Abstract Chaetomium atrobrunneum has never been reported to be associated with pneumonia. We report the isolation of C. atrobrunneum and Aspergillus fumigatus from a Chinese elderly patient with fatal pneumonia. Branched, long, and septate hyphae were observed in potassium hydroxide preparations and Gram-stained smears, and confluent C. atrobrunneum growth and a few A. fumigatus colonies were found in tracheal aspirates (nine separate occasions). These isolates were identified by conventional morphological methods and by sequencing the internal transcribed spacer and the D1/D2 domain of the 26S rRNA gene. The patient responded poorly to the combination therapy of amphotericin B and caspofungin. This report adds C. atrobrunneum to the list of fungal pneumonia in immunocompromised hosts. This case report also illustrated the presence of a growth symbiosis between Chaetomium species and A. fumigatus.
Introduction
Invasive mold infections are an important cause of mortality in immunocompromised patients. 1e3 Although aspergillosis represents the most common invasive mold infection, less commonly encountered molds, such as the mucormycetes, and Fusarium, Scedosporium, dematiaceous molds, and Acremonium species are increasingly being reported. 1e3 Chaetomium fungi are dematiaceous molds found worldwide in soil and plant debris as a saprophyte; it is also found in warm, dry areas, including on dung, straw paper, textiles, and bird feathers. 4 Chaetomium species affect healthy as well as immunocompromised individuals.
5e19 Chaetomium globosum is the most common species; other pathogenic species described are Chaetomium atrobrunneum, Chaetomium strumarium, Chaetomium perlucidum, Chaetomium funicolum, and Chaetomium murorum. 5, 8, 13, 14 Clinical features of infection have included those in association with onychomycosis, keratitis, sinusitis, lung empyema, pneumonia, and fatal disseminated cerebral mycosis.
5e19 However, C. atrobrunneum has not been previously reported to be associated with lung infection. 4,14e18 Case Report
An 89-year-old man presented at the Emergency Department of the Peking Union Medical College Hospital with a 7-day history of nausea, vomiting, constipation, cough with scanty sputum, and a noticeably decreased urine output. His medical history included biliary tract infection, colonic adenoma, and lung embolism, and he had been bed ridden for 2 years. Laboratory studies revealed leukocytosis (a white blood cell count of 15.6 Â 10 9 /L), thrombocytopenia (116 Â 10 9 /L), an elevated serum creatinine level of 607 mmol/L, and an elevated procalcitonin level of 7.75 ng/ mL. An initial chest X-ray and computed tomography demonstrated multiple foci of consolidation in both the lungs and bilateral pleural effusions. Meropenem (200 mg every 6 hours), moxifloxacin (400 mg daily), and intravenous fluconazole (200 mg daily) were initiated for the empirical treatment of pneumonia. Over the next 3 days, he developed septic shock, multiorgan failure, and worsening thrombocytopenia, and required mechanical ventilation for respiratory support. Teicoplanin (200 mg every 3 days) was administered intravenously.
Direct microscopic examination by Gram staining and potassium hydroxide (KOH) preparations of a tracheal aspirate sample collected on the 9 th hospital day revealed numerous branched, long, and septate hyphae suggestive of Aspergillus species. The ZiehleNeelsenstain analyses were negative for acid-fast bacilli. Cultures obtained from the tracheal aspirate sample yielded a few colonies of Aspergillus fumigatus; in addition, heavy and confluent growth of Chaetomium species, 3 days later, was identified by routine morphological methods ( Figures 1A and 1B) . 1 Tests for HIV-1/HIV-2 antibodies (Abbott, Wiesbaden, Germany) were negative. Fluconazole was ceased, and it was replaced by caspofungin 50 mg daily and amphotericin B deoxycholate (50 mg daily). Meropenem and teicoplanin were discontinued, and cefoperazoneesulbactam (3 g every 12 hours) and minocycline were added. The serum 1-3-b-D glucan test (Gold Mountain River, Tianjin, China) was conducted on four occasions throughout hospitalization, and each returned a negative result (<10 ng/mL). Over the next 18 days, repeated tracheal aspirate samples were collected for fungal cultures; confluent growth of Chaetomium species along with scattered growth of A. fumigatus was present on the trypticase soy agar on 5% sheep blood agar ( Figure 1A ) and on Sabouraud dextrose agar (Thermo Fisher Scientific, Waltham, MA, USA) plates on each occasion from nine separated tracheal aspirate samples. Due to uncontrolled lung infection and progressive multiorgan failure, the patient died on the 58 th hospital day.
Microbiological investigation
The surface of the colonies of the Chaetomium isolates on Sabouraud dextrose agar and sheep blood agar ( Figure 1A ) was white in color and woolly in texture on Day 3 of growth, but became gray to olivaceous after Day 7 of culture. Lactophenol cotton blue mounts from slide cultures showed septate hyphae and flask-shaped black perithecia ( Figure 1B) . The perithecia contained asci and single-celled ascospores. Ascospores were oval or lemon-shaped spores that were olive brown in color and released from the ostiole of a matured perithecium. Amplification of the fungal internal transcribed spacer (ITS) region and the D1/D2 domain of the 26S rRNA gene of the Chaetomium species was performed as previously described using the primer pairs ITS1/ITS4 and F63/R635, respectively. 20, 21 Species identification was performed by comparing the obtained ITS and D1/D2 domain sequences with those contained in the Centraalbureau voor Schimmelcultures (CBS) Fungal Biodiversity Center database as well as the GenBank database using the BioloMICSNet and BLASTn software, respectively. 20, 21 The results of ITS region and D1/D2 domain sequencing of the 26S rRNA gene of the Chaetomium species showed 100% (894/894bp) and 100% (1016/1016bp) sequence similarity to the ITS and D1/ D2domain sequences of C. atrobrunneum-type strain CBS379.66, respectively (GenBank accession numbers JX280771.1 and JX280666.1, respectively). 20, 21 Identification of A. fumigatus was based on conventional morphological identification methods. 22 Minimum inhibitory concentrations (MICs) of voriconazole and amphotericin B, as determined by the Etest method (bioMérieux, Marcy l'Etoile, France), were 0.047 mg/mL and 0.047 mg/mL, respectively, for A. fumigatus, and 0.75 mg/mL and 0.064 mg/mL, respectively, for C. atrobrunneum. Only two Etest strips of antifungal agents (voriconazole and amphotericin B) were available in our laboratory, and MICs were determined after physicians' request.
Discussion
In the current study, we report a patient who developed mixed lung infection caused by C. atrobrunneum and A. fumigatus and who died from uncontrolled lung infection, despite antifungal therapy, and lung infection-triggered progressive multiorgan failure. A total of five cases of human infection due to C. atrobrunneum have previously been reported (Table 1) . 4,14e18 In 1998, C. atrobrunneum was first detected as the pathogen of a cerebral abscess in a bone marrow transplant recipient, followed by another case, also of cerebral infection. 4, 14 In 2010, a case of mixed cutaneous infection caused by C. atrobrunneum and Clavispora lusitaniae was described in a boy with acute and severe infection around his left eyelid. 15 A further case of C. atrobrunneum keratitis was described in an adult male. 17 Of the six patients infected with C. atrobrunneum (with the addition of the present patient here), three have died: two from cerebral abscesses and one from severe pneumonia (the present patient) ( Table 1) . Our patient extends the spectrum of infection caused by C. atrobrunneum to include pneumonia. Pneumonia caused by C. globosum has previously been reported in a patient with refractory acute myeloid leukemia. 12 Interestingly, histological examination of a lung biopsy specimen revealed only branched septate hyphae, suggestive of Aspergillus species. The finding was similar to that observed in multiple tracheal aspirates in our patient. In another report, Hoppin et al 19 described a fatal case of lung empyema in a patient with acute lymphocytic leukemia where Chaetomium species was cultured from the extrapleural fluids on two separate occasions. However, the species of the fungus was not specified. In the present case, the presence of confluent growth of C. atrobrunneum accompanied by only a few colonies of A. fumigatus isolated from multiple respiratory secretions over an 18-day period supported the diagnosis of C. atrobrunneum pneumonia and A. fumigatus might have played a helper's or a stimulator's role, as suggested earlier. 13, 23 The genus of Chaetomium requires a cellulose-rich medium for sporulation, and growth of C. globosum has been noted to be often stimulated in the presence of A. fumigatus, which excretes compounds such as sugar phosphates and phosphoglyceric acid. 13, 23 Aru et al 23 reported a 73-year-old woman with chronic maxillary sinusitis and an infundibulectomy was performed. 23 Histological examination showed necrotic material with hyphae of A. fumigatus and perithecia of Chaetomium species. Lamoth et al 24 demonstrated that with two consecutive ß-D-glucan tests, the specificity was 98.9% and the estimated negative predictive value was 94.6%. The repeated (4 separated occasions) negative results for ß-D-glucan test were obtained during hospitalization, indicating that A. fumigatus is less likely to be the main pathogen in our patient. 24 However, there were no reports to indicate the usefulness for ß-Dglucan test for diagnosing invasive infection due to Chaetomium species. 4 ,5e19,24,25 Whether 1,3-ß-D-glucan is also a main cell wall constituent of Chaetomium species is not known; however, a ß-1,3-glucanase has been detected in the culture broth of Chaetomium species. 26 Consequently, the heavy growth of C. atrobrunneum from multiple deep respiratory secretions and the repeatedly negative ß-Dglucan tests in our patient suggest a more important role of C. atrobrunneum than A. fumigatus as a pathogen associated with lung infection. However, pneumonia caused by dual pathogens (C. atrobrunneum and A. fumigatus) cannot be excluded because the heavy growth of C. atrobrunneum might be stimulated by the presence of A. fumigatus in the respiratory secretions. 23 The appropriate regimen for the treatment of lung infections due to Chaetomium species is not well established. 4,5e19 In our patient, both amphotericin B and caspofungin were used for the treatment of lung infection, but a poor response was noted, although the MICs of amphotericin B against both C. atrobrunneum and A. fumigatus isolates were low. Two previous studies on in vitro susceptibility testing of Chaetomium species demonstrated that these organisms were resistant to flucytosine and fluconazole, and none of the other commonly used antifungal agents at that time (ketoconazole, itraconazole, miconazole, or amphotericin B) exhibited good in vitro fungicidal activity against this organism.
27, 28 Serena et al 28 demonstrated that among the 19 isolates of Chaetomium species tested, micafungin was not active at all, while the geometric mean MICs and minimum effective concentrations of the three triazoles (voriconazole, ravuconazole, and albaconazole) were <0.5 g/mL and <0.4 g/ mL, respectively. As for the seven isolates of C. atrobrunneum tested, the ranges of MIC and MIC 90 were 0.5e4 mg/mL and 2 mg/mL, respectively, to amphotericin B; 64 mg/mL and 64 mg/mL, respectively, to micafungin; 0.12e0.5 mg/mL and 0.5 mg/mL, respectively, to voriconazole; 0.06e1 mg/mL and 0.25 mg/mL, respectively, to ravuconazole; and 0.12e1 mg/mL and 0.25 mg/mL, respectively, to albaconazole. 28 Caspofungin was effective as a salvage therapy in patients with invasive aspergillosis who were refractory to or intolerant of the standard therapy. 29 However, the in vitro activity of caspofungin against Chaetomium species was limited. 11 Serena et al 28 also demonstrated that neither amphotericin deoxycholate, alone or in combination with itraconazole, nor its liposomal formulation has been effective in treating patients with Chaetomium infections.
In summary, we first report a fatal case of pneumonia most likely caused by C. atrobrunneum, and A. fumigatus probably played the role of a stimulator in an elderly patient, although the possibility of dual infection with A. fumigatus could not be excluded. This report adds C. atrobrunneum to the list of fungal pneumonia in immunocompromised hosts. This case report also illustrated the presence of growth symbiosis between Chaetomium species and A. fumigatus.
